Cite
MLA Citation
C.P. Selinger et al.. “P.11.2: The Impact of Infliximab Therapeutic Drug Monitoring on Decisions Made in a Virtual Biologics Clinic for Inflammatory Bowel Disease.” Digestive and liver disease, vol. 49, n.d., pp. e202–. http://access.bl.uk/ark:/81055/vdc_100045163124.0x00005a